Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(}function setPanelState(o){dom.root.classList[o?"add":"remove"](,dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Let us not speak of justice, because it's too late for that.

But the victims of thalidomide now have some redress, some peace of mind in their final years.

Late Friday, Health Minister Rona Ambrose announced the details of a compensation package for the 92 surviving Canadians who were left with severe disabilities because their mothers took the now-infamous morning sickness drug.

Story continues below advertisement

Each will receive a lump sum payment of $125,000 and an annual tax-free pension for the rest of their lives of $25,000, $75,000 or $100,000, depending on the severity of their condition. In addition, the survivors will be able to dip into a $500,000 medical assistance fund to defray the costs of mobility devices and other adaptive tools they may need.

The deal is fair, if long overdue. The only outstanding issue is the "forgotten victims" – a small group of people from that era with limb deformities who don't have medical records to prove their mothers took thalidomide. In the settlement, there is a provision for them to apply for compensation, but the bar has been set high. Some compassionate mediation is in order.

Those muttering that victims of thalidomide are getting "rich" thanks to the $100,000 pensions don't appreciate the suffering and costs that come from living a lifetime with missing limbs, flipper-like arms and damaged internal organs.

Last year, the average income of surviving thalidomide victims was a mere $14,000The history of this tragedy bears repeating.

Thalidomide, a product the German pharmaceutical company Gruenenthal, was marketed as a treatment for morning sickness and insomnia.

In Canada, free samples were distributed to doctors between 1959 and 1961 and given to expectant moms even before the drug was approved by federal regulators in April, 1961. By then, strong evidence was already emerging that thalidomide was causing miscarriages and birth defects. Yet the drug, sold under the brand names Kevadon and Talimol, remained in Canadian pharmacies until May, 1962, fully three months after it was banned in England and Germany.

We don't know exactly how many Canadian women and children were harmed by thalidomide. Worldwide, the drug is estimated to have killed 80,000 babies and left 20,000 more severely disabled. Despite taking a monstrous and inadequately tested drug, most victims never got much in the way of compensation or sympathy.

Story continues below advertisement

Thalidomide's Canadian distributor, William S. Merrell Co., made payments to parents who made a fuss, about $10,000 each, to buy their silence.

It wasn't until the late 1980s, when victims of tainted blood undertook a campaign for compensation, that thalidomide victims, with the assistance of the War Amps, got organized and asked for the same.

In 1991, there were 109 Canadians who were able to demonstrate that they were harmed by thalidomide. They received lump-sum payments ranging from $52,000 to $82,000, with the tacit understanding there would be more to come.

Last year, the 95 surviving victims, seeing their health deteriorate dramatically in their 50s, decided to make one last plea for help. They were looking for life-long pensions, like their counterparts in Germany and Britain.

Globe and Mail reporter Ingrid Peritz told their heartbreaking story, and it hit a nerve with the public, politicians and the news media.

The federal government expressed compassion but played hardball at the negotiating table. In March, it announced a $180-million settlement offer that included a $125,000 lump sum payment ($12-million in total) and a vague $168-million "medical assistance fund," from which it was in no way clear anyone would benefit.

Story continues below advertisement

The deal was widely panned and the victims refused to accept it, instead redoubling their efforts. On Monday, dozens were planning to protest on Parliament Hill.

The thought of a group of baby boomers, severely disabled by the failings of the federal regulator, limping and rolling their wheelchairs up to the entrance of Parliament, was apparently too much for the government to bear in an election year.

So on Friday, the Thalidomide Victims Association of Canada finally got a palatable deal.

It's a bittersweet moment.

Let's not forget that, for decades, corporations and governments alike were able to brush aside calls for justice on the assumption that people with disabilities are weak and ashamed, and dare not make a fuss.

The victims of thalidomide did come forward, sometimes at great personal expense to their health, their dignity, and their privacy. (Three even died during the negotiation period.)

Story continues below advertisement

In the end, they forced Canada to own up to this shameful incident in our history, albeit half a century too late.

Rarely has a group of individuals stood so tall, and we are the richer for it.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow the author of this article:

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to If you want to write a letter to the editor, please forward to

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies